East Hanover, NJ, September 25, 2008 — Novartis Pharmaceuticals Corporation today announced the launch of a complimentary dental industry-focused dinner meeting series entitled “Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals.”
The dinner meetings are designed as an adjunct to Novartis’ recently-launched web seminar series and are being offered for dentists who prefer live seminars and the opportunity to interact with the presenters as well as their peers.
A total of ten 2-hour dinner meetings (www.oralhealthdinnermeeting.com) are to be hosted between September and December, and will be presented by a rotating roster of clinicians who are leading experts on this compelling and highly relevant subject.
“Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals” will cover the following topics that every general practice dentist needs to know:
- Overview of bisphosphonates and uses in treatment of osteoporosis and metastatic
bone disease - Osteonecrosis of the jaw (ONJ) background
- ONJ frequency in oncology and osteoporosis patients treated with bisphosphonates
- Review of ONJ studies and management
The convenient schedule for the 10 Novartis dinner meetings is as follows:
City |
Date |
Time |
|
|
|
New Jersey |
Tues -10/14 |
7:00 PM |
Philadelphia |
Thurs -10/16 |
7:00 PM |
New York City |
Tues -10/21 |
7:00 PM |
Boston |
Thurs -10/23 |
7:00 PM |
Miami |
Tues -10/28 |
7:00 PM |
Chicago |
Thurs -10/30 |
7:00 PM |
Detroit |
Weds -11/05 |
7:00 PM |
Dallas |
Thurs -11/06 |
7:00 PM |
Los Angeles |
Weds – 11/12 |
7:30 PM |
San Francisco |
Thurs -11/13 |
7:00 PM |
For more details and to register for any dinner meeting session of “Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals,” visit
www.oralhealthdinnermeeting.com.